Papayannidis, C., Candoni, A., Malagola, M., Marconi, G., Manfrini, M., Simonetti, G., et al. (2015). Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia. BLOOD, 126, 2513-2513.
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia
Papayannidis, Cristina;Malagola, Michele;Marconi, Giovanni;Manfrini, Marco;Simonetti, Giorgia;Zuffa, Elisa;Abbenante, Maria Chiara;Parisi, Sarah;Paolini, Stefania;Sartor, Chiara;Franchini, Eugenia;Ottaviani, Emanuela;Venturi, Claudia;Fontana, Maria Chiara;Padella, Antonella;Guadagnuolo, Viviana;Bochicchio, Maria Teresa;Ferrari, Anna;Soverini, Simona;Testoni, Nicoletta;Baldazzi, Carmen;Russo, Domenico;Cavo, Michele;Martinelli, Giovanni
2015
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
